+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe CRISPR in Agriculture Market 2019-2025

  • ID: 4969094
  • Report
  • January 2020
  • Region: Europe
  • Orion Market Research Private Limited
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • BASF SE
  • Bayer AG
  • Caribou Bioscience Inc.
  • Cibus Ltd.
  • CRISPR Therapeutics AG
  • DowDupont Inc.
  • MORE
Europe is the well-established region that comprises few of the largest economies across the globe. The region has established agriculture research facilities in order to develop effective and productive crops. Additionally, due to increasing dependency on non-vegetarian foods such as meat, chicken, pork, and others, Europe is considered to be a significant destination for animal husbandry. Transforming agriculture practices and growing reliability on limited crops is augmenting the demand for non-vegetarian food. Therefore, gene-editing plays a critical role in maintaining fitter, healthier, and more productive farmed animals.

Major countries such as Germany, UK, and France are contributing significantly to the CRISPR in the agriculture market due to growth in animal husbandry practices and surging demand for aquaculture in countries such as Germany, Spain, and Italy. Across Europe, the demand for organic food has increased in the past 10 years. The researchers are making efforts to create more productive yields which helps farmers and food companies to attract more investment. High investment is the key to meet the growing demand amongst European consumers for organic food.

However, unfavorable regulations passed by the European Court of Justice on 25th July 2018 are restraining the investors to provide funds and hence, slowing down the R&D of gene-edited crops. The rule by the European Court of Justice states that genome-edited crops should be considered GMOs and subject to the same stringent regulations as conventional GMOs. The stringent regulations hinder the commercialization of genome editing applications across European countries. Although, in the future, separate legislation for genome editing is expected to enforce in Europe which is expected to benefit researchers and food companies.

Research Methodology

The market study of the Europe CRISPR in Agriculture market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.

Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Europe CRISPR in Agriculture Market Research and Analysis by End-users
2. Europe CRISPR in Agriculture Market Research and Analysis by Target Type

The Report Covers
  • Comprehensive research methodology of the Europe CRISPR in Agriculture market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Europe CRISPR in Agriculture market.
  • Insights about market determinants which are stimulating the Europe CRISPR in Agriculture market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • BASF SE
  • Bayer AG
  • Caribou Bioscience Inc.
  • Cibus Ltd.
  • CRISPR Therapeutics AG
  • DowDupont Inc.
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. Europe CRISPR in Agriculture Market by End-User
5.1.1. Academic & Research Institutes
5.1.2. Biotech Companies
5.2. EuropeCRISPR in Agriculture Market by Target Type
5.2.1. Crops
5.2.2. Livestock
5.2.3. Aquaculture Driving and Sports

6. Regional Analysis
6.1. Germany
6.2. UK
6.3. Italy
6.4. Spain
6.5. France
6.6. Rest of Europe

7. Company Profiles
7.1. BASF SE
7.2. Bayer AG
7.3. Caribou Bioscience Inc.
7.4. Cibus Ltd.
7.5. CRISPR Therapeutics AG
7.6. DowDupont Inc.
7.7. E. I. du Pont de Nemours and Company
7.8. ERS Genomics
7.9. Horizon Discovery Group, PLC
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • BASF SE
  • Bayer AG
  • Caribou Bioscience Inc.
  • Cibus Ltd.
  • CRISPR Therapeutics AG
  • DowDupont Inc.
  • E. I. du Pont de Nemours and Company
  • ERS Genomics
  • Horizon Discovery Group, PLC
Note: Product cover images may vary from those shown
Adroll
adroll